05:52 PM EDT, 08/07/2024 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on August 06, 2024, sold 28,000 shares in Avidity Biosciences ( RNA ) for $1,213,822. Following the Form 4 filing with the SEC, Boyce has control over a total of 205,043 shares of the company, with 205,043 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990124000127/xslF345X03/wk-form4_1723067208.xml

Price: 41.12, Change: +0.01, Percent Change: +0.02